Skip to main content

Labia Majora Augmentation (Autologous Fat Grafting)

Autologous fat grafting (lipofilling) is the most commonly used and best-evidenced technique for labia majora augmentation — restoration of volume to atrophic, deflated, or hypoplastic labia majora using the patient's own adipose tissue. The Jabbour 2017 Aesthet Surg J SR remains the largest synthesis (4 fat-grafting studies / 183 patients pooled), and modern series add the regenerative dimension of microfat / nanofat / SVF-enriched preparations.[1][2][3] For positioning vs other female cosmetic options see Cosmetic Genital Surgery — Female.

Society positioning

The ACOG 2020 Committee Opinion No. 795 states that female genital cosmetic procedures are not medically indicated in patients without structural or functional abnormalities, that safety and effectiveness have not been established, and that patient-satisfaction reports should not serve as evidence of clinical effectiveness.[4] The FIGO 2025 Statement echoes this position. Mandatory BDD screening belongs at the front of every consultation. There are no RCTs comparing fat grafting to other augmentation methods for the labia majora; only 2 of 9 studies in the Jabbour SR were prospective.[1]

Indications​

  • Age-related volume loss / atrophy — postmenopausal deflated, wrinkled labia majora.[2][1]
  • Genitourinary syndrome of menopause (GSM) — vulvovaginal atrophy with dryness and dyspareunia. Microfat to the labia majora plus nanofat to the vaginal mucosa is the regenerative-medicine application of choice (Menkes 2021).[2]
  • Correcting the labia minora-to-majora ratio — augmenting the majora "masks" conservatively reduced minora and reduces the extent of labiaplasty needed (Hersant 2018 combined approach).[5]
  • Post-surgical / oncologic reconstruction — after ablative surgery (e.g., for Bowen's disease) where flap reconstruction has not restored volume or relieved mucosal-exposure symptoms (Vogt 2011).[6]
  • Gender-affirming surgery — labial fat grafting after penile inversion vaginoplasty for flattened labia majora (the most common indication, 83% of cases per Patel 2021). Patients requiring fat grafting were more likely to have had introital stenosis (33% vs 6%, p = 0.007) and prolonged granulation tissue > 6 weeks (83% vs 32%, p = 0.01).[7]
  • Aesthetic dissatisfaction — congenital hypoplasia or weight-loss-related deflation.[1][8]

Surgical technique​

Fat harvest​

  • Donor sites: abdomen, inner thighs, flanks, mons pubis. The mons pubis donor has dual benefit — simultaneous mons reduction provides graft material (Cihantimur 2021 "360" technique).[3]
  • Standard tumescent technique with small-bore liposuction cannulas.

Fat processing​

MethodDescriptionUse
Standard centrifugationHarvested fat centrifuged → oil / aqueous fraction / purified fat. Most common method.[1]Volumetric augmentation
MicrofatStandard processed fatLabia majora volume[2]
NanofatMechanically emulsified and filtered → liquid rich in adipose-derived stem cells (ADSCs) and stromal vascular fraction (SVF)Vaginal-mucosa trophic / regenerative effect (not volume)[2]
MAFT (micro-autologous fat transplantation)Specialized gun delivers small fat parcels (~ 1/240 mL per injection)Uniform distribution; improved graft survival[9]
SVF-enriched fatADSCs + SVF concentrate (Cihantimur 360)Higher regenerative-cell load[3]

Injection technique​

  • Blunt-tipped cannulas through small stab incisions.
  • Fan-shaped distribution in multiple tissue planes (subcutaneous, intralabial) — maximizes graft-to-recipient contact.
  • Small aliquots per pass; avoid large boluses (central necrosis).

Reported volumes per session​

SeriesTechniqueVolume per session
Jabbour 2017 SR[1]Various fat grafting18–120 mL total
Menkes 2021[2]Microfat + nanofatNot separately specified
Lai 2023 (MAFT)[9]Micro-autologous fat transplantation20.8 mL vulva / mons + 21.9 mL vagina
Cihantimur 2021 (360)[3]SVF-enriched fatNot specified per site
Hersant 2018[5]Standard fat grafting (combined with conservative labiaplasty)Not specified

Outcomes​

SeriesnPopulationSatisfaction / endpointFollow-up
Cihantimur 2021 (360)[3]97AestheticFGSIS 17.7 → 20.9 (6 mo, p < 0.001) → 22.2 (12 mo, p = 0.013)12 mo
Menkes 2021 (microfat / nanofat)[2]50GSM (mean age 53)VHI + FSD significantly improved; 80% normalized at 6 mo; stable at 18 mo18 mo
Hersant 2018 (fat + conservative labiaplasty)[5]21Aesthetic81% satisfied / very satisfied; one minor wound separation (4.7%)Not specified
Lai 2023 (MAFT)[9]20Aesthetic / functionalFSFI 43.8 → 68.6 (p < 0.001)6 mo
Cihantimur 2013 (genital beautification)[8]124Combined procedures95.2% happy; 3.2% very happy12 mo
Patel 2021 (post-PIV)[7]6Gender-affirmingSafe and effective; no complicationsVariable
Toplu 2021 (combined surgical / non-surgical)[10]37Aesthetic94.5% satisfied / very satisfied12 mo

Functional and histologic benefits​

Beyond volume, fat grafting produces regenerative tissue effects.

  • Lai 2023 MAFT — vulvovaginal fat grafting via the MAFT gun significantly increased neocollagenesis, neoangiogenesis, and estrogen-receptor expression in vaginal tissue, with decreased protein gene product 9.5 (associated with neuropathic pain). FSFI improved across all domains, with particular benefit for dyspareunia and lubrication.[9]
  • Menkes 2021 — microfat / nanofat in GSM patients gave particular benefit for dryness and dyspareunia, with results stable through 18 months.[2]

Complications​

No major or life-threatening complications have been reported across published labia majora fat-grafting series.[1] Minor complications:

  • Ecchymosis of labia majora and clitoral hood (transient; resolved by POD 7).[3]
  • Tenderness in the pubic area (transient).[3]
  • Pain at vaginal entrance points (transient).[3]
  • No infection, edema, lipoma, or granuloma formation in the largest single series (Cihantimur 2021 n = 97).[3]
  • No flap necrosis, infections, pain, or sexual dysfunction in the Hersant 2018 combined-technique series; one small wound separation (4.7%) resolved spontaneously.[5]
  • Wound dehiscence 8.1% in the Cihantimur 2013 genital-beautification series (which included concurrent labiaplasty, not fat grafting in isolation).[8]

Fat-graft retention and durability​

Volumetric retention in the labia majora has not been objectively quantified by MRI / ultrasound in any published series. Available signals:

  • Stable results at 18 months in all Menkes 2021 GSM patients.[2]
  • Continued FGSIS improvement from 6 → 12 months in Cihantimur 2021 — suggests ongoing tissue remodeling rather than progressive resorption.[3]
  • General fat-grafting literature suggests 40–60% volume retention at 1 year in other anatomic sites; the labia majora's rich vascularity may favor higher retention.[11]
  • Repeat sessions are uncommonly reported in the published series, but counseling should reflect the possibility.[12]

Comparison with alternative augmentation methods​

MethodMaterialPer-session volumeDurationKey advantagesKey limits
Autologous fat graftingPatient's own fat18–120 mLLong-lasting (stable 12–18 mo)[1][2]Autologous; regenerative (ADSCs); natural feel; no foreign-body reactionDonor site; variable retention; possible overcorrection
Hyaluronic acid (HA)HA filler 19–21 mg/mL2–6 mLTemporary (~ 12 mo+)[12]Office procedure; no donor; reversible (hyaluronidase)Temporary; repeat sessions; cost
Calcium hydroxyapatite (CaHA)CaHA fillerSmall volumesTemporary[13]Biostimulatory; officeLimited data; temporary
Dermal fat graftAutologous dermal-fat blockSurgical blockStable long-term[14]Stable volume; no resorptionSurgical harvest; donor-site scar

Combined approaches​

  • Fat grafting + conservative labiaplasty (Hersant 2018) — augmenting the majora "masks" the minora, allowing more conservative labia minora reduction with fewer complications.[5]
  • 360 Vaginal Beautification (Cihantimur 2021) — labia majora fat grafting + vaginal tightening using SVF-enriched fat.[3]
  • "Genital beautification" concept (Cihantimur 2013) — labia minora reduction + labia majora fat augmentation + labial brightening by laser + mons-pubis liposuction ± vaginal tightening (95.2% satisfaction at 1 yr).[8]
  • Surgical + non-surgical (Toplu 2021) — labiaplasty + fat injection to mons / labia majora + fractional CO₂ laser (94.5% satisfaction).[10]
  • Microfat + nanofat (Menkes 2021) — microfat for labia majora volume; nanofat for vaginal regeneration; particularly effective for GSM.[2]

Special population — gender-affirming surgery​

Patel 2021 Aesthet Surg J (n = 6) — labial fat grafting after penile inversion vaginoplasty is safe and effective for flattened labia majora, the most common indication (83% of cases). Patients requiring fat grafting were more likely to have prior introital stenosis (33% vs 6%, p = 0.007) and prolonged granulation tissue > 6 weeks (83% vs 32%, p = 0.01) after initial vaginoplasty — increased scarring and contracture predict the need for subsequent fat grafting.[7]

Limitations​

  • ACOG 2020 — safety and effectiveness of labia majora augmentation have not been well documented; high satisfaction in non-validated reports does not establish clinical effectiveness.[4]
  • No RCTs comparing fat grafting to other augmentation methods.[1]
  • Only 2 of 9 studies in the Jabbour SR were prospective.[1]
  • No standardized approach or consensus guidelines for labia majora augmentation.[1]
  • No volumetric retention measurements by MRI / ultrasound in any published series.
  • Patients should be counseled about possible repeat sessions and the unpredictability of fat-graft survival.
  • BDD screening should occur before surgery per ACOG.[4]

Postoperative management​

  • Activity restriction. Avoid intercourse, tampon use, and strenuous exercise for 2–4 weeks; protect the donor site per general lipofilling protocol.
  • Wound care. Ice 48–72 h; loose-fitting clothing.
  • Compression / pressure at the donor site; avoid pressure on the recipient site so as not to compress the graft.
  • Follow-up. 1 week (donor + recipient sites), 6 weeks, 6 months, 12 months — with FGSIS / FSFI / VHI / FSD as relevant to indication.
  • Counseling on durability. Counsel that fat resorption can occur; a second session may be needed for the desired volume.

See Also​

References​

1. Jabbour S, Kechichian E, Hersant B, et al. Labia majora augmentation: a systematic review of the literature. Aesthet Surg J. 2017;37(10):1157–1164. doi:10.1093/asj/sjx056

2. Menkes S, SidAhmed-Mezi M, Meningaud JP, et al. Microfat and nanofat grafting in genital rejuvenation. Aesthet Surg J. 2021;41(9):1060–1067. doi:10.1093/asj/sjaa118

3. Cihantimur B, Aglamis O, Ozsular Y. 360 genital fat transfer. Aesthet Plast Surg. 2021;45(6):2996–3002. doi:10.1007/s00266-021-02488-w

4. Committee on Gynecologic Practice, American College of Obstetricians and Gynecologists. Elective female genital cosmetic surgery: ACOG Committee Opinion No. 795. Obstet Gynecol. 2020;135(1):e36–e42. doi:10.1097/AOG.0000000000003616

5. Hersant B, Jabbour S, Noel W, et al. Labia majora augmentation combined with minimal labia minora resection: a safe and global approach to the external female genitalia. Ann Plast Surg. 2018;80(4):323–327. doi:10.1097/SAP.0000000000001435

6. Vogt PM, Herold C, Rennekampff HO. Autologous fat transplantation for labia majora reconstruction. Aesthet Plast Surg. 2011;35(5):913–915. doi:10.1007/s00266-011-9664-5

7. Patel V, Morrison SD, Gujural D, Satterwhite T. Labial fat grafting after penile inversion vaginoplasty. Aesthet Surg J. 2021;41(3):NP55–NP64. doi:10.1093/asj/sjaa431

8. Cihantimur B, Herold C. Genital beautification: a concept that offers more than reduction of the labia minora. Aesthet Plast Surg. 2013;37(6):1128–1133. doi:10.1007/s00266-013-0211-4

9. Lai YW, Wu SH, Chou PR, et al. Autologous fat grafting in female genital area improves sexual function by increasing collagenesis, angiogenesis, and estrogen receptors. Aesthet Surg J. 2023;43(8):872–884. doi:10.1093/asj/sjad040

10. Toplu G, Altinel D. Genital beautification and rejuvenation with combined use of surgical and non-surgical methods. Aesthet Plast Surg. 2021;45(2):758–768. doi:10.1007/s00266-020-01980-z

11. Kim JH, Kim SE, Kim YJ, Kim YW, Cheon YW. Comparison of volume retention and biocompatibility of acellular dermal matrix/hyaluronic acid filler to autologous fat grafts in a mouse model. Aesthet Plast Surg. 2020;44(3):986–992. doi:10.1007/s00266-020-01680-8

12. Fasola E, Gazzola R. Labia majora augmentation with hyaluronic acid filler: technique and results. Aesthet Surg J. 2016;36(10):1155–1163. doi:10.1093/asj/sjw083

13. Vilela CL, de Lima Faria GE, Boggio RF. Treatment of atrophy of the labia majora: calcium hydroxyapatite or hyaluronic acid? Aesthet Plast Surg. 2024;48(3):472–477. doi:10.1007/s00266-023-03617-3

14. Salgado CJ, Tang JC, Desrosiers AE. Use of dermal fat graft for augmentation of the labia majora. J Plast Reconstr Aesthet Surg. 2012;65(2):267–270. doi:10.1016/j.bjps.2011.07.010